<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cancer Imaging</journal-id><journal-id journal-id-type="iso-abbrev">Cancer Imaging</journal-id><journal-title-group><journal-title>Cancer Imaging</journal-title></journal-title-group><issn pub-type="ppub">1740-5025</issn><issn pub-type="epub">1470-7330</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">4601786</article-id><article-id pub-id-type="publisher-id">1470-7330-15-S1-O40</article-id><article-id pub-id-type="doi">10.1186/1470-7330-15-S1-O40</article-id><article-categories><subj-group subj-group-type="heading"><subject>Oral Presentation</subject></subj-group></article-categories><title-group><article-title>Brain lesions in oncology patients: recognising metastatic versus non metastatic lesions</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Rich</surname><given-names>Philip</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib></contrib-group><aff id="I1"><label>1</label>Department of Neuroradiology, St George's University Hospitals NHS FT, Consultant Neuroradiologist, The Royal Marsden NHS FT, UK</aff><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>2</day><month>10</month><year>2015</year></pub-date><volume>15</volume><issue>Suppl 1</issue><supplement><named-content content-type="supplement-title">Proceedings of the International Cancer Imaging Society (ICIS) 15th Annual Teaching Course</named-content><named-content content-type="supplement-sponsor">Publication charges for this supplement were funded through the International Cancer Imaging Society by support received from Siemens Healthcare GmbH.</named-content></supplement><fpage>O40</fpage><lpage>O40</lpage><permissions><copyright-statement>Copyright &#x000a9; 2015 Rich</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Rich</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xlink:href="http://www.cancerimagingjournal.com/content/15/S1/O40"/><conference><conf-date>5-7 October 2015</conf-date><conf-name>International Cancer Imaging Society Meeting and 15th Annual Teaching Course (ICIS 2015)</conf-name><conf-loc>London, UK</conf-loc></conference></article-meta></front><body><sec><title/><p>Therapeutic developments across a range of primary tumours have resulted in more cancer patients with cerebral metastatic disease undergoing active management and imaging surveillance. There has been an increase in the caseload and range of disease presenting to oncology and neuro-oncology MDTs. In this lecture I will present examples of intracranial metastases, discuss differences in appearance according to primary site and tips for differentiating from primary intracranial tumours and non-neoplastic mimics.</p></sec></body></article>